Pivotal Study to Evaluate Safety and Immunogenicity of a Live-Attenuated Chikungunya Virus Vaccine Candidate in Adults
Clinical trial NCT04546724 · COMPLETED
Trial details
- NCT number
- NCT04546724
- Sponsor
- Valneva Austria GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-17
- Primary completion
- 2021-05-19
- Enrollment
- 4128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.